Hillsborough, NC, United States of America

Matthew W Kostura


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):

Title: Matthew W Kostura: Innovator in Cancer Treatment

Introduction

Matthew W Kostura is a notable inventor based in Hillsborough, NC (US). He has made significant contributions to the field of medicine, particularly in the treatment of hyperproliferative diseases such as cancer. His innovative approaches and methods have the potential to change the landscape of cancer treatment.

Latest Patents

Kostura holds a patent for "Methods of using substituted pyrazole and pyrazole compounds for treatment of hyperproliferative diseases." This patent discloses methods for treating hyperproliferative disorders, including cancer. The methods involve arresting the cell cycle in cancer cells and inhibiting glutathione synthesis in these cells. The associated compounds are particularly effective against cancers with a mutant KRAS gene. His work in this area is groundbreaking and offers new avenues for therapeutic interventions.

Career Highlights

Matthew W Kostura is currently associated with Bantam Pharmaceutical, LLC, where he continues to develop innovative solutions for complex medical challenges. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Kostura has collaborated with notable professionals in his field, including Arshad M Siddiqui and Stephane Ciblat. These collaborations have enhanced his research efforts and contributed to the advancement of cancer treatment methodologies.

Conclusion

Matthew W Kostura's work exemplifies the spirit of innovation in the medical field. His contributions to cancer treatment through his patented methods and compounds are invaluable. His ongoing efforts at Bantam Pharmaceutical, LLC highlight his commitment to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…